Dec. 7: Two analysts issued research notes suggesting that there may be little upside left for their stock.
Dec. 11: Barron's says that overvalued based on fundamentals relative to close competitors. Example: market cap 11x sales, while closest competitor only 1.3 times.
Dec. 21: RIMM to annouce prelim third quarter results. Everyone agrees the slightest hint of bad news will sent their prices down.
Share prices have already retracted from their high of almost $143. Investors are evidently weary.
Merry Christmas!